Fermer ce champ de recherche.
Fermer ce champ de recherche.

Frontiers : prédateurs ou non ?

Points clés

Certains me disent que le groupe Frontiers ne fait pas partie des prédateurs.. Je les entends, mais quand je reçois les emails ci-dessous, je m'interroge..  Je précise que je n'ai jamais reviewé pour Frontiers ni publié dans ce groupe. J Beall a classé les revues de ce groupe comme prédatrices, et il a eu des ennuis !

En principe, les bonnes revues n'envoient pas ces types d'emails :

Dear Dr. Maisonneuve,

I am wondering if you received our earlier email (found below my signature)?

I would love to discuss new developments in your field, and whether there would be an opportunity to create an editorial project around this (called Research Topics). 

Please let me know if you would like to discuss this further. I would be happy to send you some more information, or we could schedule a phone call at a time that is convenient for you.

Best regards,

Kirsten Martin
Research Topic Manager
Frontiers | Editorial Office – Research Topic Team

1005 Lausanne, Switzerland 
Office T +41 21 510 17 15
Meet the Frontiers team

Frontiers journals lead in citations in their fields and rank in the top Impact Factor percentiles. Read the full analysis here.

You have received this message because you have previously been in contact with Frontiers or because, due to your profile and expertise, it was thought likely that it would be of interest to you. If you have received this message in error or if you do not wish to receive further communications from us, please click here or send us an email with the word Unsubscribe. Frontiers will not divulge or share your personal information to or with third parties. © Frontiers Media SA. All Rights Reserved.


Dear Dr. Maisonneuve,

Thank you for reviewing for Frontiers Pharmacology, your contribution is much appreciated! I am reaching out to some of our reviewers to see whether there are any new developments in your field that might justify a dedicated article collection?

Frontiers empowers researchers to publish their work open-access and to shape discussion in their field through our Research Topics – collections of peer reviewed articles devoted entirely to new areas of research.

Frontiers in Pharmacology is 2nd most-cited open access journal in Pharmacology and Pharmacy with an Impact Factor of 4.400 and led by Chief Editor Prof. Heike Wulff.
We have published several article collections to date, such as: The changing faces of glutathione, a cellular protagonist, edited by Alfonso Pompella and Alessandro Corti.
The editorial team and I would be happy to discuss potential themes with you and provide you with additional information about the project. Please let me know if you have any questions.
Partagez cet article sur les réseaux:

Laisser un commentaire

Votre adresse e-mail ne sera pas publiée. Les champs obligatoires sont indiqués avec *

Articles populaires

Archives mensuelles



Inscrivez-vous à notre newsletter mensuelle


Vous pourriez aussi aimer